Torskal pioneers eco-friendly green nanoparticles for safer, sustainable solutions in cancer treatment and nanomedicine innovation.
Sainte Clotilde, Réunion – 09/04/2025 – Torskal Nanoscience, the pioneer in green nanotechnology innovation, is pleased to announce a major breakthrough in green nanoparticles development for commercialization, leading to an eco-friendly, biocompatible solution for contemporary problems in cancer therapy as well as nanomedicine.
Green nanoparticles engineered through eco-friendly, plant-based syntheses are the future of nanomaterials, marrying scientific accuracy with ecological stewardship. While the global focus on sustainability, clean technology, and healthier intervention is increasing, Torskal’s innovative approach is establishing the new gold standard for the sector.
The Rise of Green Nanotechnology
Nanotechnology has revolutionized various fields, ranging from cosmetics and electronics to medicine and agriculture. Most conventional methods of synthesizing nanoparticles, however, involve the use of toxic chemicals, high energy usage, and the generation of dangerous wastes. These processes are detrimental to human health as well as the environment, raising doubt about their long-term sustainability.
Taking center stage is green nanotechnology, the innovative, ecofriendly solution. Leading the charge is Torskal, which uses plant extracts and natural reductants in its green synthesis of gold nanoparticles, completely doing away with the use of toxins. Not only is this approach environmentally sustainable, but it delivers nanoparticles with higher biocompatibility as well as therapeutic action.
Scientific Innovation with Global Impact
Torskal’s green technology for gold nanoparticles is patented, allowing for controlled size, shape, and surface features—a critical group of parameters affecting their performance in biological applications. The company is currently manufacturing gold nanoparticles of different sizes (specifically, 15nm and 40nm), optimized for use in applications such as:
Targeted drug delivery: Allowing direct delivery of therapeutic compounds directly to the sites of tumor growth, minimizing side effects while increasing efficacy
Near-infrared laser photothermal therapy (nanophototherapy): Near infrared light is used to heat gold nanoparticles, killing cancer cells but not neighboring healthy tissue.
Imaging and diagnostics: Increasing the contrast in imaging methods such as MRI and CT scans for increased accuracy in disease detection at an earlier stage.
Green nanoparticles are particularly promising for applications in oncology. Preclinical research demonstrates Torskal’s biocompatible nanoparticles of gold are tolerated in the human system extensively without any adverse effects. They can be accurately localized in cancerous cells, minimizing toxicity while achieving maximum therapeutic effects—holding out the possibility of safer, more effective treatments for patients.
Green Production, High-Performance Product
Torskal’s green chemistry method leverages the antioxidant potentials of plant extracts found in La Réunion plants as well as other tropical plants, famed for their antioxidant content. Natural compounds function as reducing as well as stabilizing reagents in gold nanoparticles syntheses without the use of chemical reagents like sodium borohydride or hydrazine.
This approach offers several benefits:
Non-toxic and biodegradable end products
Lower environmental impact
Scalability and affordability
High Dispersion and Stability in Biological Media
Torskal green nanoparticles are made in controlled quality environments for consistency, safety, and performance. As environmental sustainability and medical safety regulations become increasingly stringent, Torskal is poised for growth in meeting rising demand for green nanotechnology solutions globally.
Commitment towards Research and Worldwide Collaboration Torskal partners in close collaboration with top research centres, universities, as well as French, European, as well as Indian Ocean region, hospitals. Torskal is also involved in various international research collaboration related to the creation of green nanomedicine platforms for the management of cancer and infectious diseases.
Its broad team comprises chemists, biologists, nanotechnologists, oncologists, and pharmacologists who collaborate together to bring lab breakthroughs into the clinic, as treatments.
“We are committed firmly to open science and collaboration. Medicine’s future is global as well as interdisciplinary,” averred Torskal Research Head. “By merging nanoscience with green chemistry, we are establishing an entirely new healthcare paradigm that is safe, effective, and earth-friendly.”
Market Readiness and Vision for the Future
As healthcare and biotech fields upgrade towards greener, safer options, green nanoparticles are fast becoming a primary facilitator of future medical technologies. The green nanotechnology market is expected to see substantial growth, driven in particular by growth in investment in precision medicine, personalized treatments, and green production processes, according to analysts.
Torskal is pursuing the commercialization of its green nanomaterials both through licenses, collaborative development agreements for the clinic, and direct sales of research-grade nanoparticles. Colloidal gold nanoparticles are already for sale for research in academic and industrial settings on www.torskal.com.
With a clear path to clinical validation and commercialization, Torskal would be a leading global company in nanomedicine with products responding both to medical requirements as well as ethical requirements.
About Torskal Torskal Nanoscience is a La Réunion-headquartered French biotechnology firm that focuses on green nanotechnologies research for health and scientific uses. Building on sustainability, innovation, and social responsibility principles, Torskal designs innovative nanomaterials through environmentally friendly methodologies with the aim of transforming cancer care through photothermal therapy as well as targeted drug delivery.
Contact Information:
📍 Torskal Nanoscience
2 rue Maxime Rivière, Sainte Clotilde, 97490, La Réunion, France
📞 (+262) 262 93 88 31 | 📱 (+262) 692 72 02 92
📧 [email protected]
🌐 www.torskal.com
© 2024 Crivva - Business Promotion. All rights reserved.